These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19406107)

  • 1. nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms.
    Sarter M; Parikh V; Howe WM
    Biochem Pharmacol; 2009 Oct; 78(7):658-67. PubMed ID: 19406107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
    Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M
    Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging the cortical cholinergic system to enhance attention.
    Demeter E; Sarter M
    Neuropharmacology; 2013 Jan; 64(1):294-304. PubMed ID: 22796110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic α4β2 Cholinergic Receptor Influences on Dorsolateral Prefrontal Cortical Neuronal Firing during a Working Memory Task.
    Sun Y; Yang Y; Galvin VC; Yang S; Arnsten AF; Wang M
    J Neurosci; 2017 May; 37(21):5366-5377. PubMed ID: 28450546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
    Parikh V; Man K; Decker MW; Sarter M
    J Neurosci; 2008 Apr; 28(14):3769-80. PubMed ID: 18385335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.
    Poorthuis RB; Goriounova NA; Couey JJ; Mansvelder HD
    Biochem Pharmacol; 2009 Oct; 78(7):668-76. PubMed ID: 19426718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.
    Ochoa EL; Lasalde-Dominicci J
    Cell Mol Neurobiol; 2007 Aug; 27(5):609-39. PubMed ID: 17554626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches.
    Sarter M; Paolone G
    Behav Neurosci; 2011 Dec; 125(6):825-35. PubMed ID: 22122146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nicotinic receptors in shaping and functioning of the glutamatergic system: a window into cognitive pathology.
    Molas S; Dierssen M
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():315-25. PubMed ID: 24879992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex.
    Wallace TL; Bertrand D
    Biochem Pharmacol; 2013 Jun; 85(12):1713-20. PubMed ID: 23628449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex.
    Cloke JM; Nguyen R; Chung BY; Wasserman DI; De Lisio S; Kim JC; Bailey CD; Winters BD
    J Neurosci; 2016 Dec; 36(50):12570-12585. PubMed ID: 27974613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release.
    Bortz DM; Mikkelsen JD; Bruno JP
    Neuroscience; 2013; 255():55-67. PubMed ID: 24095692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.
    Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS
    Curr Opin Investig Drugs; 2008 Jan; 9(1):47-56. PubMed ID: 18183531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats.
    Nikiforuk A; Litwa E; Krawczyk M; Popik P; Arias H
    Pharmacol Rep; 2020 Jun; 72(3):589-599. PubMed ID: 32207091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic modulation of neuronal networks: from receptors to cognition.
    Mansvelder HD; van Aerde KI; Couey JJ; Brussaard AB
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):292-305. PubMed ID: 16001117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms.
    Dickinson JA; Kew JN; Wonnacott S
    Mol Pharmacol; 2008 Aug; 74(2):348-59. PubMed ID: 18445710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.
    Wilens TE; Decker MW
    Biochem Pharmacol; 2007 Oct; 74(8):1212-23. PubMed ID: 17689498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.